MEDIGENE AG NA O.N./ DE000A1X3W00 /
| 2024-04-19 2:25:16 PM | Chg. -0.12 | Volume | Bid2:25:16 PM | Ask2:25:16 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.84EUR | -5.88% | 14,050 Turnover: 27,352.75 |
1.84Bid Size: 1,400 | 1.94Ask Size: 1,300 | 47.65 mill.EUR | 0.00% | - |
Assets
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 4.3000 | 4.3000 | 8.8000 | 6.9000 | 4.9000 | ||||||
| Intangible Assets | 34.1000 | 34 | 33.5000 | 31.6000 | 30.1000 | ||||||
| Long-Term Investments | 5.7000 | 25.6000 | 3.6000 | 3.3000 | 0.0000 | ||||||
| Fixed Assets | 48.6000 | 67.4000 | 51.5000 | 42.1000 | 35.3000 | ||||||
| Inventories | 7.7000 | 7.3000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 27.7000 | 27.4000 | 34.7000 | 30 | 22.4000 | ||||||
| Current Assets | 63.3000 | 62.2000 | 57.7000 | 32.7000 | 24.2000 | ||||||
| Total Assets | 111.9000 | 129.6000 | 109.2000 | 74.8000 | 59.5000 | ||||||
Liabilities
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .7000 | 1.4000 | 1.4000 | .4000 | .5000 | ||||||
| Long-term debt | 7.6000 | .8000 | - | .4000 | .2000 | ||||||
| Liabilities to Banks | 12.4000 | 4.1000 | 3.2000 | .7000 | .4000 | ||||||
| Provisions | 2.2000 | 3 | 2.4000 | 3.4000 | 2.5600 | ||||||
| Liabilities | 25.8000 | 22.2000 | 27.4000 | 21.6000 | 14.7000 | ||||||
| Share Capital | 22.3010 | 24.5570 | 24.5630 | 24.5630 | 24.5630 | ||||||
| Total Equity | 86.2000 | 107.4000 | 81.8000 | 53.2000 | 44.8000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 111.9000 | 129.6000 | 109.2000 | 74.8000 | 59.5000 | ||||||
Income Statement
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7.7000 | 7.6000 | 10.5000 | 8 | 10.5000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -13.4000 | -17.8000 | -20.2000 | -28.7000 | -10 | ||||||
| Interest Income | -1.4000 | .1000 | -.3000 | -.3400 | -.3800 | ||||||
| Income Before Taxes | -12.9000 | -17 | -19.9000 | -28.4000 | -10.3000 | ||||||
| Income Taxes | .6000 | .0500 | .0400 | .5000 | -.3000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -13.6000 | -17 | -20 | -28.9000 | -10 | ||||||
Per Share
Cash Flow
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -20.8000 | -10.1000 | -16.4000 | -24.8000 | -10.8000 | ||||||
| Cash Flow from Investing Activities | 15.2000 | -19.5000 | 24.2000 | 21.1000 | 4 | ||||||
| Cash Flow from Financing | 18.7000 | 29.3000 | -.5000 | -.8000 | -1 | ||||||
| Decrease / Increase in Cash | 13.1000 | -.3000 | 7.3000 | -4.6000 | -7.6000 | ||||||
| Employees | 91 | 98 | 123 | 142 | 64 | ||||||
